Ritalin-SR en es it fr

Ritalin-SR Brand names, Ritalin-SR Analogs

Ritalin-SR Brand Names Mixture

  • No information avaliable

Ritalin-SR Chemical_Formula


Ritalin-SR RX_link


Ritalin-SR fda sheet

Ritalin-SR FDA

Ritalin-SR msds (material safety sheet)

Ritalin-SR MSDS

Ritalin-SR Synthesis Reference

M. Hartmann, L. Panizzon, U.S. Pat. 2,507,631 (1950)

Ritalin-SR Molecular Weight

233.306 g/mol

Ritalin-SR Melting Point


Ritalin-SR H2O Solubility


Ritalin-SR State


Ritalin-SR LogP


Ritalin-SR Dosage Forms

Tablets; Tablets (sustained release)

Ritalin-SR Indication

For use as an integral part of a total treatment program which typically includes other remedial measures (psychological, educational, social) for a stabilizing effect in children with a behavioral syndrome characterized by the following group of developmentally inappropriate symptoms: moderate-to-severe distractibility, short attention span, hyperactivity, emotional lability, and impulsivity.

Ritalin-SR Pharmacology

Methylphenidate is a central nervous system stimulant used most commonly in the treatment of attention-deficit disorders in children and for narcolepsy. Its mechanisms appear to be similar to those of dextroamphetamine.

Ritalin-SR Absorption

Readily absorbed in a biphasic manner. It reaches peak absorption at approximately two hours for the first phase and five hours for the second phase. Bioavailability is low (approximately 30%)

Ritalin-SR side effects and Toxicity

Symptoms of overdose include vomiting, agitation, tremors, hyperreflexia, muscle twitching, convulsions (may be followed by coma), euphoria, confusion, hallucinations, delirium, sweating, flushing, headache, hyperpyrexia, tachycardia, palpitations, cardiac arrhythmias, hypertension, mydriasis, and dryness of mucous membranes. LD50=190mg/kg (orally in mice)

Ritalin-SR Patient Information

Ritalin-SR Organisms Affected

Humans and other mammals